COVID-19 and stroke: from the cases to the causes
- PMID: 33583167
- DOI: 10.1515/revneuro-2020-0136
COVID-19 and stroke: from the cases to the causes
Abstract
During COVID-19 pandemic, a wide variety of stroke typologies have been described in patients affected by SARS-CoV-2. Investigating the case reports of acute stroke in COVID-19 patients, published since the beginning of the pandemic, we tried to trace the pathogenic mechanisms of stroke during SARS-CoV-2 infection. We conducted a systematic review analyzing demographic data, cerebrovascular risk factors, NIHSS score, vascular territory involvement and laboratory findings of 168 patients described in 89 studies, from a pool of 1243 records. Based on our results, we have identified different stroke profiles: (1) cerebral large vessel disease (CLVD) profile with a low disability, simultaneous onset of COVID-19 and stroke symptoms, good outcome and low serum levels of D-dimer and CRP; (2) intracranial bleeding (IB) profile with high disability, poor outcome and low levels of serum markers of inflammation and coagulopathy; (3) CLVD profile with a short time-lapse between COVID-19 symptoms and stroke onset, high neurological disability and very high systemic inflammatory markers; (4) multiple thrombo-embolic disease (MTED) profile with older patients, many comorbidities, disabling stroke, poor outcome, evident alteration of coagulation tests and high serum levels of both D-dimer and CRP. We therefore summarized these different profiles in a spectrum similar to that of visible light, where the violet-blue band included IB and CSVD with low inflammation and prothrombotic activity, the green-yellow band included CLVD with high inflammation and moderate prothrombotic activity and the orange-red band for MTED with moderate-high levels of inflammation and very high prothrombotic activity.
Keywords: COVID-19; D-dimer; SARS-COV-2; intracranial bleeding; small vessel; stroke.
© 2021 Walter de Gruyter GmbH, Berlin/Boston.
References
-
- Adams, H.P.Jr, Bendixen, B.H., Kappelle, L.J., Biller, J., Love, B.B., Gordon, D.L., and Marsh, E.E. (1993). Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in acute stroke treatment. Stroke 24: 35–41, https://doi.org/10.1161/01.str.24.1.35.
-
- Al-Dalahmah, O., Thakur, K.T., Nordvig, A.S., Prust, M.L., Roth, W., Lignelli, A., Uhlemann, A.C., Miller, E.H., Kunnath-Velayudhan, S., Del Portillo, A., et al.. (2020). Neuronophagia and microglial nodules in a SARS-CoV-2 patient with cerebellar hemorrhage. Acta Neuropathol. Commun. 8: 147, https://doi.org/10.1186/s40478-020-01024-2.
-
- Al-Mufti, F., Becker, C., Kamal, H., Alshammari, H., Dodson, V., Nuoman, R., Dakay, K., Cooper, J., Gulko, E., and Gandhi, C.D. (2020). Acute cerebrovascular disorders and vasculopathies associated with significant mortality in SARS-CoV-2 patients admitted to the intensive care unit in the New York epicenter. J. Stroke Cerebrovasc. Dis. 30: 105429.
-
- Al-Olama, M., Rashid, A., and Garozzo, D. (2020). COVID-19-associated meningoencephalitis complicated with intracranial hemorrhage: a case report. Acta Neurochir. 162: 1495–1499, https://doi.org/10.1007/s00701-020-04402-w.
-
- Al Saiegh, F., Ghosh, R., Leibold, A., Avery, M.B., Schmidt, R.F., Theofanis, T., Mouchtouris, N., Philipp, L., Peiper, S.C., Wang, Z.X., et al.. (2020). Status of SARS-CoV-2 in cerebrospinal fluid of patients with COVID-19 and stroke. J. Neurol. Neurosurg. Psychiatry 91: 846–848, https://doi.org/10.1136/jnnp-2020-323522.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous